Expand US market presence for dysphagia diagnostic and treatment device ¿ Budget 2021
True Angle Medical Technologies Inc.
10 enregistrements totalisant 3,337,693.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Développement économique Canada pour les Prairies | $2,577,157 | 2 enregistrements |
| Conseil national de recherches Canada | $760,536 | 8 enregistrements |
Enregistrements
Expand US market presence for dysphagia diagnostic and treatment device - Budget 2021
True Angle Medical Technologies is focused on the development of novel sensing technologies. Our first product, the Mobili-T™, is a system created for people who suffer from swallowing difficulties. T...
This project will accelerate True Angle's newly launched B2B Enterprise sales strategy. The firm initially approached the US market with a Business-to-Consumer (B2C) subscription-based model, and is n...
This project will continue to accelerate True Angle's land and expand enterprise sales strategy. The strategy involves connecting at the VP and C-suite level in large healthcare organizations that emp...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
CIIP - China - SDS with Trustworthy (Beijing)Technology Co., Ltd: IRAP Project summary. Currently, the state-of-the-art in jaw reconstruction is to use fully-guided surgical design and simulation (SD...
The project will focus on generating market traction in the US for a new mobile technology that was developed in Canada for patients with dysphagia. The project will focus on strategically segmenting...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.